Health & Biotech
As it awaits crucial FDA approval Botanix reckons Aussies have a penchant for backing high-risk companies
PharmAust eyes Phase-3 trial after positive results from canine cancer drug
ASX Health Stocks: Emyria partners with Pax Centre to provide psychedelics therapy for PTSD sufferers
Dr Boreham’s Crucible: Tag it and bag it – Bluechiip’s ready to come in from the cold
Argenica confirms safety of ARG-007 in Phase-1 trial, makes preparations for Phase-2
ASX Health Stocks: Rhythm crashes 45pc after withdrawing TGA application for ColoSTAT
Check Up: Almost half a billion US dollars raised to bring back mammoth, dodo, and Tassie tiger
ScoPo’s Powerplays: ASX health stocks fall but keep watchful eye on upcoming catalysts
Incannex commences manufacture of psilocybin for trials and commercial applications
ASX Health Stocks: AFT Pharma wins crucial US FDA approval for Maxigesic pain tablets
PharmAust’s interim analysis could set the stage for expedited Phase-2 MND trial
EZZ inks strategic partnership with two leading Pharmas; aims to bring world-leading dietary products to market
Incannex begins major Phase-2 trial for CBD-enhanced combination drug for rheumatoid arthritis
PharmAust lands key European patent for MPL combinations in cancer
ASX Health Stocks: Trajan delivers another strong half as it upgrades guidance
As dementia takes toll on Aussies, here’s why Alterity and these ASX biotechs are in the box seat
ScoPo’s Powerplays: ASX health stocks have lacklustre week as Monash IVF continues to gain market share
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.
